Form 4: Elevance Health Director Receives Stock Grant

Director Robert L. Dixon Jr. acquired 563 deferred stock units as part of the Elevance Health, Inc. Board of Directors Compensation Program.

Summary

• Director Robert L. Dixon Jr. was granted 563 deferred stock units on May 13, 2026.
• The grant was issued under the Elevance Health, Inc. Board of Directors Compensation Program.
• Following this transaction, the director's total beneficial ownership of common stock is 10,885 shares.
• The units are payable in common stock upon the earlier of five years from the grant date or the director's departure from the board.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding standard director compensation, having no material impact on the company's financial outlook.

Positives

• The transaction reflects standard director compensation practices, aligning the interests of the board member with long-term shareholder value.

Negatives

• None identified.

Risks

• The value of the deferred stock units is subject to the future market performance of Elevance Health common stock.

Future Outlook

The deferred stock units are scheduled to vest and become payable in common stock in five years or upon the director's separation from the board, whichever occurs first.

Industry Context

StockSavvy.ai notes that this filing represents routine corporate governance activity regarding director compensation, which is standard practice among large-cap healthcare companies to ensure board alignment with equity performance.

Comparison to Industry Standards

• The use of deferred stock units for board compensation is a standard industry practice for S&P 500 companies to promote long-term retention and alignment.
• The structure of the grant is consistent with typical equity-based compensation plans for directors at major health insurance providers.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine compensation event.

Next Steps

• The director will hold the units until the earlier of five years or their departure from the board.

Key Dates

Keywords

Elevance Health, ELV, Director Compensation, Form 4, Insider Transaction, Deferred Stock Units